{"title":"A Perspective Review of Cancer Therapy (Part II): Adoptive Cell Transfer, Metabolic Therapy, and Artificial Intelligence","authors":"Alberto Pajuelo","doi":"10.15354/si.23.re838","DOIUrl":null,"url":null,"abstract":"In recent years, there has been significant advancement in cancer therapy, with the emergence of novel and inventive methods that provide hope to patients. An advanced approach is adoptive cell transfer, which utilizes the immune system’s potential by modifying T cells to identify and eliminate cancer cells. The implementation of this individualized method has demonstrated encouraging effects across different cancer types, resulting in enhanced prognoses for numerous individuals. Metabolic therapy has emerged as a possible treatment technique, alongside adoptive cell transfer. This therapeutic method seeks to interrupt the growth and survival of cancer cells by specifically targeting their abnormal metabolism. Moreover, artificial intelligence (AI) is transforming cancer care by assisting in the identification of diseases, forecasting the likely course of illness, and devising treatment strategies. Artificial intelligence algorithms employ extensive data analysis to identify patterns and anomalies that may not be readily apparent to human specialists in isolation. Oncologists can enhance patient outcomes and reduce unwanted effects by integrating adoptive cell transfer, metabolic therapy, and AI technologies to provide personalized treatments.","PeriodicalId":150634,"journal":{"name":"Science Insights","volume":" 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15354/si.23.re838","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In recent years, there has been significant advancement in cancer therapy, with the emergence of novel and inventive methods that provide hope to patients. An advanced approach is adoptive cell transfer, which utilizes the immune system’s potential by modifying T cells to identify and eliminate cancer cells. The implementation of this individualized method has demonstrated encouraging effects across different cancer types, resulting in enhanced prognoses for numerous individuals. Metabolic therapy has emerged as a possible treatment technique, alongside adoptive cell transfer. This therapeutic method seeks to interrupt the growth and survival of cancer cells by specifically targeting their abnormal metabolism. Moreover, artificial intelligence (AI) is transforming cancer care by assisting in the identification of diseases, forecasting the likely course of illness, and devising treatment strategies. Artificial intelligence algorithms employ extensive data analysis to identify patterns and anomalies that may not be readily apparent to human specialists in isolation. Oncologists can enhance patient outcomes and reduce unwanted effects by integrating adoptive cell transfer, metabolic therapy, and AI technologies to provide personalized treatments.
近年来,癌症治疗取得了重大进展,出现了一些新颖、创造性的方法,为患者带来了希望。其中一种先进的方法是采用性细胞转移,它通过改造 T 细胞来识别和消除癌细胞,从而利用免疫系统的潜能。这种个体化方法的实施在不同癌症类型中都取得了令人鼓舞的效果,从而改善了许多患者的预后。代谢疗法已成为一种可能的治疗技术,与收养性细胞转移疗法并驾齐驱。这种治疗方法旨在通过专门针对癌细胞的异常新陈代谢,阻断癌细胞的生长和存活。此外,人工智能(AI)通过协助识别疾病、预测可能的病程和制定治疗策略,正在改变癌症治疗。人工智能算法利用广泛的数据分析来识别人类专家可能不易察觉的模式和异常现象。肿瘤学家可以通过整合收养细胞转移、代谢疗法和人工智能技术来提供个性化治疗,从而提高患者的治疗效果,减少不必要的影响。